A detailed history of Israel Englander (Millennium Management LLC) transactions in Rallybio Corp stock. As of the latest transaction made, Millennium Management LLC holds 342,944 shares of RLYB stock, worth $294,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
342,944
Previous 459,966 25.44%
Holding current value
$294,931
Previous $616,000 34.9%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.09 - $1.45 $127,553 - $169,681
-117,022 Reduced 25.44%
342,944 $401,000
Q2 2024

Aug 14, 2024

BUY
$1.34 - $2.98 $352,670 - $784,297
263,187 Added 133.75%
459,966 $616,000
Q1 2024

May 15, 2024

BUY
$1.25 - $2.4 $201,510 - $386,899
161,208 Added 453.2%
196,779 $364,000
Q4 2023

Feb 14, 2024

BUY
$1.91 - $4.39 $48,571 - $111,637
25,430 Added 250.76%
35,571 $85,000
Q2 2023

Aug 14, 2023

BUY
$4.31 - $8.89 $43,707 - $90,153
10,141 New
10,141 $57,000

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $27.6M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.